SOURCE: Cambridge Healthtech Institute

Cambridge Healthtech Institute

June 02, 2016 13:30 ET

Keynote Speakers and Final Agenda Announced for Targeting the Microbiome 2016

Experts From GlaxoSmithKline, Brigham and Women's Hospital, MIT and More Discuss Using the Microbiome as a Tool for Therapeutic Development

NEEDHAM, MA--(Marketwired - June 02, 2016) - Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, announced the speaker lineup and final agenda for the 2nd Annual Targeting the Microbiome, taking place September 20-22, 2016 in Boston at the 14th Annual Discovery on Target Conference. This two-part meeting provides interactive sessions and panel discussions with leading researchers and thought leaders who will discuss how their work in this field has and will continue to have tremendous impact in generating personalized diagnostics and therapeutics to improve disease treatment and human health.

Keynote presentations will focus on the dynamics of the microbiome on health and disease and be delivered by Niels Klitgord, Ph.D., Bioinformatician at Human Longevity, Inc., and David T.S. Hayman, Ph.D., Senior Lecturer in Veterinary Public Health, Co-Director of mEpiLab, OIE Collaborating Centre Infectious Disease Research Centre, Hopkirk Research Institute, Massey University, New Zealand. Klitgord's presentation will present an overview of Human Longevity, Inc.'s on-going effort to elucidate the microbiome role in human health and disease that is based on whole genome sequencing and analysis of over 3,000 microbiome samples from well phenotyped cohorts. Hayman's presentation will focus on discovering and modeling pathogen sharing in humans, gorillas and livestock in Uganda.

Klitgord and Hayman join an impressive group of distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees. They will present the scientific and clinical research correlating microbiome compositions with targeted diseases and using the microbiome as a tool for therapeutic, diagnostic and product development.

For more information on Targeting the Microbiome, including a full speaker line-up and detailed agendas, visit: Discoveryontarget.com/Targeting-Microbiome

About Cambridge Healthtech Institute (www.healthtech.com)
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation, Bio-IT World, Clinical Informatics News and Diagnostics World.

Contact Information